90% of patients respond to new blood cancer treatment in trial
Anew cancer therapy developed at Jerusalem’s Hadassah-University Medical Center had a 90% response rate in a new clinical trial, with over half of patients going into total remission. The CAR-T therapy — which arms the body’s own immune cells to fight cancer — was able to send multiple myeloma, an extremely deadly cancer that impacts the immune system, into remission.
Continue Reading![](https://s0.storage.snapzu.com/favicons/f/r/e/e/www.freethink.com.png)
Join the Discussion